Fig. 8. Inhibition of subcutaneous tumour growth by ADAMTS12. (A) SCID mice were injected with parental A549 cells or with cells from an A549 clone (A549-TS12) expressing ADAMTS12. Tumour growth was followed until day 37, and tumour volumes were calculated after measurements were taken with a calliper. (B) Representative subcutaneous tumours at day 37 following injection are shown for mice that received A549 or A549-TS12 cells